ESH Video


January 01, 1970


ESH 3rd Translational Research Conference:

Erythropoiesis Control and Ineffective Erythropoiesis:

from bench to bedside


March 03-05, 2023

Paris, France








Do not miss the opportunity,
the Conference starts in a month!



About the programme:

The ESH conference on Erythropoiesis control and Ineffective Erythropoiesis, which will held in Paris in March 3rd-5th 2023 aims at providing an education program on basic science related to normal and pathological erythropoiesis and megakaryopoiesis giving opportunities to share experiences in clinical practice.

Erythropoiesis is a continuous process leading to the daily production of 1011 red cells. The bone marrow microenvironment supports and educates the hematopoietic progenitors. Recent advances deeply increase our understanding of erythropoiesis control and its deregulation in pathological conditions thanks to the studies of chromatin organization and post-transcriptional regulatory mechanisms occurring during erythroid cell differentiation.

Ineffective erythropoiesis relies on various mechanisms that may combine in some diseases or demonstrate specificities supporting particular phenotypes and opening the avenue for targeted therapies.

Identifying the causes of treatment resistance and following the dynamics of erythroid response will provide valuable information to improve patients care through the design of innovative clinical trials.



Main scientific topics:

• Metabolism in erythroid cells
• Proteome remodeling and cellular clearance in erythropoiesis
• Fetal globin silencing
• Bone marrow cell expansion and engraftment
• Stressed erythropoiesis in MDS
• Stressed erythropoiesis in haemoglobinopathies and other haemolytic anaemia
• Clinical and diagnosis
• Gene therapy and genome editing
• Pharmacological approaches


Learning objectives:
1. Increasing our understanding of regulatory mechanisms of erythropoiesis
2. Post-transcriptional regulation of erythropoiesis
3. Listing the causes of ineffective erythropoiesis
and the potential targets for innovative treatments


The programme will include:

Plenary Sessions - Simultaneous Meet the Experts Sessions

Round Table Discussions - Poster Presentations - Short Oral Communications

Ample time for in-depth discussion



The scientific programme is available!


The Programme of the Conference has been reviewed
and approved for CME-CPD accreditation by the European Board
for Accreditation in Haematology (EBAH). 

The EHA-CME Unit has approved this educational activity
for 18 CME-CPD credits


For more information, click here!